Eye Movement Desensitization and Reprocessing (EMDR) in Complex Psychotrauma

Efficiency of the Use of Benevolent Memories in the EMDR Protocol in Complex Psychotrauma (Benevolence Study)

This study wants to demonstrate the effectiveness of combining a positive memory with "recommended" therapy based on EMDR in reducing the disturbance that patients with complex psychotrauma may experience. The positive memory will be called "benevolent memory" (SB) or "less worse memory" (SMP).

This is an interventional study, prospective, exploratory, comparative, randomized, controlled versus reference treatment protocol, open.

Patients will be seen 16 times for the purposes of the study. They will be hospitalized during therapy. Discharge from hospitalization occurs during follow-up depending on the patient's condition.

They will be evaluated over a period of 4 to 6 weeks between the start (Day 0 = Week 1) and the end of treatment (visit week 12). These visits will coincide with treatment sessions with the EMDR ± SB / SMP protocol, as part of the support of their complex psychotrauma. At the end of treatment, the patient will be evaluated during follow-up visits at Month 1, Month 3 and Month 6.

Inclusion Criteria:

• Patient suffering from a combination of a period of complex trauma and a disturbance triggered by situations in adulthood;
• Having signed an informed consent form to participate in the study.

Exclusion Criteria:

• Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
• Patient seeking legal benefit from participating in the study;
• Patient previously treated with EMDR;
• Patient unable to understand the information related to the study (linguistic, psychological, cognitive reason, etc.);
• Untreated epileptic patient;
• Patient with severe oculomotor disorders;
• Patient in hypomanic phase;
• Patient treated with high dose corticosteroids;
• Patient with alcohol and / or drug misuse in the 7 days preceding inclusion;
• Pregnant or likely to be (of childbearing age, without effective contraception) or breastfeeding;
• Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
• Patient not beneficiary of a social security scheme.